Bornhäuser M - Search Results

1

Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT.

Frankiewicz A, Peczynski C, Giebel S, Harrington A, Socié G, Niederwieser D, Scheid C, Bornhäuser M, Kröger N, Elmaagacli A, Afanasyev B, Dreger P, Rössig C, Blaise D, Kratz C, Yakoub-Agha I, Kremens B, Niemeyer CM, Wulf G, Blau I, Penack O, Greinix H, Basak GW. Frankiewicz A, et al. Among authors: bornhauser m. Front Immunol. 2020 Jul 23;11:1537. doi: 10.3389/fimmu.2020.01537. eCollection 2020. Front Immunol. 2020. PMID: 32793210 Free PMC article.

2

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

Bornhäuser M, Schuler U, Pörksen G, Naumann R, Geissler G, Thiede C, Schwerdtfeger R, Ehninger G, Thiede HM. Bornhäuser M, et al. Transplantation. 1999 Feb 27;67(4):499-504. doi: 10.1097/00007890-199902270-00001. Transplantation. 1999. PMID: 10071016

3

Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.

Ringdén O, Remberger M, Runde V, Bornhäuser M, Blau IW, Basara N, Hölig K, Beelen DW, Hägglund H, Basu O, Ehninger G, Fauser AA. Ringdén O, et al. Among authors: bornhauser m. Blood. 1999 Jul 15;94(2):455-64. Blood. 1999. PMID: 10397713 Free article. Clinical Trial.

4

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin.

Bornhäuser M, Thiede C, Schuler U, Platzbecker U, Freiberg-Richter J, Helwig A, Plettig R, Röllig C, Naumann R, Kroschinsky F, Neubauer A, Ehninger G. Bornhäuser M, et al. Bone Marrow Transplant. 2000 Jul;26(2):119-25. doi: 10.1038/sj.bmt.1702500. Bone Marrow Transplant. 2000. PMID: 10918420

5

Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation.

Ringdén O, Remberger M, Runde V, Bornhäuser M, Blau IW, Basara N, Hölig K, Beelen DW, Hägglund H, Basu O, Ehninger G, Fauser AA. Ringdén O, et al. Among authors: bornhauser m. Bone Marrow Transplant. 2000 May;25 Suppl 2:S6-8. doi: 10.1038/sj.bmt.1702343. Bone Marrow Transplant. 2000. PMID: 10933177 Clinical Trial.

6

Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation.

Schimmelpfennig C, Naumann R, Zuberbier T, Ordemann R, Baurmann H, Beyer J, Siegert W, Bornhäuser M, Ehninger G. Schimmelpfennig C, et al. Among authors: bornhauser m. Bone Marrow Transplant. 2001 Apr;27(7):753-5. doi: 10.1038/sj.bmt.1702835. Bone Marrow Transplant. 2001. PMID: 11360117

7

Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.

Bornhäuser M, Thiede C, Platzbecker U, Jenke A, Helwig A, Plettig R, Freiberg-Richter J, Röllig C, Geissler G, Lutterbeck K, Oelschlagel U, Ehninger G. Bornhäuser M, et al. Clin Cancer Res. 2001 Aug;7(8):2254-62. Clin Cancer Res. 2001. PMID: 11489799 Clinical Trial.

8

Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis.

Bornhäuser M, Kiehl M, Siegert W, Schetelig J, Hertenstein B, Martin H, Schwerdtfeger R, Sayer HG, Runde V, Kröger N, Theuser C, Ehninger G; Cooperative German Transplant Study Group. Bornhäuser M, et al. Br J Haematol. 2001 Oct;115(1):119-24. doi: 10.1046/j.1365-2141.2001.03074.x. Br J Haematol. 2001. PMID: 11722421 Free article.

9

Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.

Schetelig J, Kröger N, Held TK, Thiede C, Krusch A, Zabelina T, Dubiel M, Rick O, Bornhäuser M, Ehninger G, Zander AR, Siegert W. Schetelig J, et al. Among authors: bornhauser m. Haematologica. 2002 Mar;87(3):299-305. Haematologica. 2002. PMID: 11869943

10

Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients.

Kiehl MG, Schäfer-Eckart K, Kröger M, Bornhäuser M, Basara N, Blau IW, Kienast J, Fauser AA, Ehninger G, Armstrong VW, Shipkova M. Kiehl MG, et al. Among authors: bornhauser m. Transplant Proc. 2002 Nov;34(7):2922-4. doi: 10.1016/s0041-1345(02)03489-9. Transplant Proc. 2002. PMID: 12431658 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

668 results

Search Page

Filters